Published in Hepatology on March 01, 1991
Dietary saturated and monounsaturated fats protect against acute acetaminophen hepatotoxicity by altering fatty acid composition of liver microsomal membrane in rats. Lipids Health Dis (2011) 0.83
Amelioration of cisplatin-induced nephrotoxicity by grape seed extract and fish oil is mediated by lowering oxidative stress and DNA damage. Cytotechnology (2013) 0.81
Diets with corn oil and/or low protein increase acute acetaminophen hepatotoxicity compared to diets with beef tallow in a rat model. Nutr Res Pract (2009) 0.80
Comparative effect of olive oil and fish oil supplementation in combating gentamicin induced nephrotoxicity in rats. Indian J Clin Biochem (2005) 0.79
Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury. Front Physiol (2012) 0.76
Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol (2000) 2.24
Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol (1996) 2.00
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol (1989) 1.50
Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. J Pharmacol Exp Ther (1976) 1.41
Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest (1983) 1.31
The systemic availability of oral glutathione. Eur J Clin Pharmacol (1992) 1.29
Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology (1984) 1.23
Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J Clin Invest (1984) 1.18
Kava hepatotoxicity. Ann Intern Med (2001) 1.13
Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology (1995) 1.13
Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS (1992) 1.10
Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett (1997) 1.10
Regulation of hepatic glutathione turnover in rats in vivo and evidence for kinetic homogeneity of the hepatic glutathione pool. J Clin Invest (1981) 1.07
Therapeutic doses of acetaminophen stimulate the turnover of cysteine and glutathione in man. J Hepatol (1987) 1.06
Altered bile acid metabolism in primary biliary cirrhosis. Dig Dis Sci (1981) 1.03
High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest (1991) 1.01
The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther (1980) 1.00
Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J Pharmacol Exp Ther (1984) 0.96
Clinical value of the bile acid breath test. Evaluation of the Mayo Clinic experience. Mayo Clin Proc (1978) 0.96
Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity. Gastroenterology (1976) 0.93
Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest (1987) 0.92
Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. Br J Rheumatol (1997) 0.92
Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest (1996) 0.92
Toxic doses of acetaminophen suppress hepatic glutathione synthesis in rats. Hepatology (1982) 0.91
Oxidant stress and hepatic necrosis in rats treated with diquat. J Pharmacol Exp Ther (1985) 0.90
Glutathione metabolism in activated human neutrophils: stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur J Clin Invest (1991) 0.90
Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans. J Pharmacol Exp Ther (1985) 0.90
Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol (1992) 0.89
Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester. J Surg Res (1999) 0.89
Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun (1995) 0.88
Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. J Hepatol (1991) 0.87
Oxidation of hydrazine metabolites formed from isoniazid. Clin Pharmacol Ther (1985) 0.86
Liver injury due to verapamil. Hepatogastroenterology (1988) 0.85
Oxidant stress during reperfusion of ischemic liver: no evidence for a role of xanthine oxidase. Hepatology (1988) 0.85
Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther (1999) 0.85
L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J Pharmacol Exp Ther (1991) 0.84
Breath test with isotopes of carbon: progress and potential. J Lab Clin Med (1977) 0.84
Prednisolone stimulates hepatic glutathione synthesis in mice. Protection by prednisolone against acetaminophen hepatotoxicity in vivo. J Hepatol (1993) 0.84
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metab Dispos (1998) 0.83
Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol (1986) 0.83
Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine. J Hepatol (1998) 0.83
Increased urinary losses of carnitine during ifosfamide chemotherapy. Cancer Chemother Pharmacol (1999) 0.83
Disposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione. J Pharmacol Exp Ther (1995) 0.82
Chemical nature of reactive intermediates as determinant of toxicologic responses. Drug Metab Rev (1982) 0.80
Decreased glutathione in patients with anorexia nervosa. Risk factor for toxic liver injury? Eur J Clin Nutr (2004) 0.80
Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet (1980) 0.80
Postischemic ATP levels predict hepatic function 24 hours following ischemia in the rat. Experientia (1988) 0.80
Plasmaperfusion for the treatment of intractable pruritus of cholestasis. Mayo Clin Proc (1978) 0.80
Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses (1995) 0.79
Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid. J Pharmacol Exp Ther (1987) 0.79
Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol (2006) 0.79
Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid. Eur J Clin Pharmacol (1987) 0.79
Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology (1989) 0.79
Effect of allopurinol on oxidant stress and hepatic function following ischemia and reperfusion in the rat. Liver (1988) 0.78
Oral bioavailability of mesna tablets. Cancer Chemother Pharmacol (1993) 0.78
Endotoxin causes neutrophil-independent oxidative stress in rats. J Appl Physiol (1985) (1988) 0.78
Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion. Cancer Chemother Pharmacol (2000) 0.77
Solvent isotope effect on bile formation in the rat. Biochem J (1995) 0.77
Ethanol decreases plasma sulphydryls in man: effect of disulfiram. Eur J Clin Invest (1988) 0.77
Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res (1994) 0.77
Plasma glutathione disulfide as an index of oxidant stress in vivo: effects of carbon tetrachloride, dimethylnitrosamine, nitrofurantoin, metronidazole, doxorubicin and diquat. Res Commun Chem Pathol Pharmacol (1984) 0.77
Effect of one month of lactitol treatment on calcium metabolism in man. Eur J Clin Pharmacol (1989) 0.77
Depletion of circulating cyst(e)ine by oral and intravenous mesna. Br J Cancer (1993) 0.76
Diet and fatty acids: can fish substitute for fish oil? Clin Exp Rheumatol (1991) 0.76
Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man. Hepatology (1985) 0.76
Effect of oral glutathione monoethyl ester and glutathione on circulating and hepatic sulfhydrils in the rat. Pharmacol Toxicol (1994) 0.76
Alkylation and peroxidation injury from chemically reactive metabolites. Adv Exp Med Biol (1981) 0.76
Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol (2005) 0.75
Effect of methylene blue on the disposition of ethanol. Alcohol Alcohol (2000) 0.75
Exercise-induced hyperammonemia in patients with compensated chronic liver disease. Scand J Gastroenterol (1990) 0.75
[Assessment of surgical risk in patients with decreased liver function]. Ther Umsch (1987) 0.75
Effect of cyclosporine A on the demethylation of aminopyrine in rats in vivo. Eur Surg Res (1995) 0.75
Analysis of isoniazid, acetylhydrazine and [15N2]acetylhydrazine in serum by capillary gas chromatography-ammonia chemical ionization mass spectrometry. J Chromatogr (1987) 0.75
Drug-induced liver injury. Hosp Pract (1978) 0.75
Increased concentrations of omega-3 fatty acids in milk and platelet rich plasma of grass-fed cows. Int J Vitam Nutr Res (1993) 0.75
Peptidoleukotrienes increase the efflux of glutathione from perfused rat liver. Prostaglandins Leukot Essent Fatty Acids (1993) 0.75
Lactitol: gastrointestinal absorption and effect on blood lactate in healthy volunteers and patients with cirrhosis. Eur J Clin Pharmacol (1988) 0.75
Stimulation of hepatic efflux and turnover of glutathione by methionine in the rat. Eur J Clin Invest (1986) 0.75
Depletion of bile acids and bilirubin in dogs with biliary obstruction by plasmaperfusion of USP-charcoal-coated glass beads. Int J Artif Organs (1980) 0.75
Josamycin and troleandomycin increase hepatic glutathione turnover in rats. Biochem Pharmacol (1987) 0.75
Oxidant stress and potentiation of ischemia/reperfusion injury to the perfused rat liver by human polymorphonuclear leukocytes. J Hepatol (1994) 0.75
Removal of bile acids and bilirubin by plasmaperfusion of U.S.P. charcoal-coated glass beads. J Lab Clin Med (1979) 0.75
[Clinical pharmacology of calcium antagonists]. Schweiz Med Wochenschr (1987) 0.75
[Biological changes caused by ethanol: their sequelae and importance in the diagnosis of alcoholism]. Ther Umsch (1990) 0.75
[Phytotherapy]. Ther Umsch (2002) 0.75
In vivo regulation of hepatic glutathione synthesis: effects of food deprivation or glutathione depletion by electrophilic compounds. Adv Exp Med Biol (1981) 0.75
Effect of oral and intravenous S,N-diacetylcysteine monoethyl ester on circulating and hepatic sulfhydryls in the Rat. J Pharmacol Exp Ther (2000) 0.75
Overview of alkylation and peroxidation mechanisms in acute lethal hepatocellular injury by chemically reactive metabolites. Semin Liver Dis (1981) 0.75
[Pharmacotherapy with endogenous substances]. Ther Umsch (1995) 0.75
[Drug-induced involuntary movements]. Ther Umsch (1988) 0.75
[Diagnosis and management of patients with chronic hepatitis]. Ther Umsch (1987) 0.75
[Treatment of alcoholic liver diseases and psychiatric and psychosocial problems]. Ther Umsch (1998) 0.75
[Drug damage to the liver: role of reactive metabolites and pharmacokinetics]. Schweiz Med Wochenschr (1985) 0.75